MRIS: DANGERS OF GADOLINIUM EXPOSURE

Just this year, the FDA finally updated safety notices on gadolinium-based MRI contrast dyes after even more evidence confirmed that gadolinium toxins in the dye can remain in the brain, bones, and kidneys for years after the MRI was taken. Studies have shown neurotoxicity, pain syndromes, and long-term connective-tissue inflammation problems associated with the toxic dye.

This seminar explores why relying on increasingly aggressive imaging can backfire, how contrast dyes disrupts natural mineral pathways, and how clinicians are now seeking safer alternatives. Many patients are turning to natural detoxification strategies to eliminate the heavy metals from their MRI.


These statement have not been evaluated by the Food and Drug Administration. Products or services at Gilead Balm are not intended to diagnose, treat, cure, or prevent any disease.